Author

C. Alcon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

J. Montero· 2 shared A. Letai· 1 shared A. Manzano-Munoz· 1 shared A. Martiniere· 1 shared A. Soriano· 1 shared A. Villanueva· 1 shared C. Francis· 1 shared C. Maurel· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Montero

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell line-specific network models of ER+ breast cancer identify PI3Kα inhibitor sensitivity factors and drug combinations

J. Gomez Tejeda Zanudo, P. Mao, C. Alcon, K. J. Kowalski, G. N. Johnson, G. Xu, J. Baselga, M. Scaltriti, A. Letai, J. Montero, R. Albert, N. Wagle

bioRxiv · Aug 25, 2020Cancer Biology

A plasma membrane nanoplatform ensures signal specificity during osmotic signaling in plants

M. Smokvarska, C. Francis, M. P. Platre, J.-B. Fiche, C. Alcon, X. Dumont, P. Nacry, V. Bayle, M. Nollmann, C. Maurel, Y. Jaillais, A. Martiniere

The paper shows that Rho GTPase nanodomains at the plasma membrane ensure signal specificity during osmotic signaling in plants by transducing reactive oxygen species production.

bioRxiv · Jun 14, 2020Plant Biology

Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.

C. Alcon, A. Manzano-Munoz, E. Prada, J. Mora, A. Soriano, G. Guillen, S. Gallego, J. Roma, J. Samitier, A. Villanueva, J. Montero

This study uses dynamic BH3 Profiling to identify BH3 mimetic combinations that enhance chemotherapy efficacy and prevent resistance in rhabdomyosarcoma.

bioRxiv · Jan 24, 2020Cancer Biology